NSAID use may lower rates of colorectal cancer in older women

Share this article:

Nonsteroidal anti-inflammatory drugs (NSAIDs) may be associated with lower colorectal cancer mortality among postmenopausal women, particularly in those who use these agents for longer periods of time before a diagnosis is made.

In study results presented at the 10th American Association for Cancer Research (AACR) International Conference on Frontiers in Cancer Prevention Research, held October 22-25, 2011, in Boston, Massachusetts, Anna E. Coghill, MPH, and colleagues described their analysis of the effect of NSAID use on colorectal cancer mortality among 160,143 postmenopausal women participating in the Women's Health Initiative (WHI) clinical trials and WHI observational study. None of the subjects had a history of colorectal cancer at the time of enrollment. Coghill, a doctoral student in epidemiology at the University of Washington and Fred Hutchinson Cancer Research Center, in Seattle, Washington, and her team reviewed medical records and death certificates to confirm 2,119 cases of colorectal cancer and 492 deaths caused by the disease.

Although reported use of NSAIDs at study baseline (including aspirin, ibuprofen, and prescription NSAIDs) was not linked with colorectal cancer mortality, women who reported NSAID use at both baseline and year 3 experienced reductions in colorectal cancer mortality of approximately 30% compared with those who did not report use at both time points. Women who had used NSAIDs for at least 10 years before enrolling in the study carried a significantly reduced risk for colorectal cancer mortality than did women who reported no use.

The researchers concluded that the relationship between long-term NSAID use and reduced colorectal cancer mortality may indicate that these agents have an effect on decreasing the incidence of new tumors and on lowering rates of disease progression.

Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Web Exclusives

Black Women's Health Study (BWHS) shows exercise improves breast cancer risk for ...

This recently published study found strong evidence linking physical exercise to a lower rate of breast cancer in African American women, a group in which previous evidence has been lacking.

Cancer-causing mechanism behind Myc oncogene uncovered

A protein present at high levels in more than half of all human cancers drives cell growth by blocking the expression of just a handful of genes involved in DNA packaging and cell death.

Galectin-1 protein allows brain tumors to evade the immune system

Brain tumors fly under the radar of the body's defense forces by coating their cells with extra amounts of a specific protein, according to new research.